Literature DB >> 25529627

Chronic kidney disease (CKD) and NAFLD: time for awareness and screening.

Giovanni Musso1, James H Tabibian2, Michael Charlton2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25529627     DOI： 10.1016/j.jhep.2014.11.044

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

Review 1.  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Niki Katsiki; Michael Doumas; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

2.  NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity.

Authors:  Firas Alhasson; Diptadip Dattaroy; Suvarthi Das; Varun Chandrashekaran; Ratanesh Kumar Seth; Rick G Schnellmann; Saurabh Chatterjee
Journal:  Am J Physiol Renal Physiol       Date:  2015-10-07

Review 3.  Nonalcoholic fatty liver disease - A multisystem disease?

Authors:  Ivana Mikolasevic; Sandra Milic; Tamara Turk Wensveen; Ivana Grgic; Ivan Jakopcic; Davor Stimac; Felix Wensveen; Lidija Orlic
Journal:  World J Gastroenterol       Date:  2016-11-21       Impact factor: 5.742

4.  High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease.

Authors:  Firas Alhasson; Ratanesh Kumar Seth; Sutapa Sarkar; Diana A Kimono; Muayad S Albadrani; Diptadip Dattaroy; Varun Chandrashekaran; Geoffrey I Scott; Samir Raychoudhury; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Redox Biol       Date:  2018-04-07       Impact factor: 11.799

Review 5.  Comorbidities and Metabolic Derangement of NAFLD.

Authors:  Ki Bae Bang; Yong Kyun Cho
Journal:  J Lifestyle Med       Date:  2015-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.